
In this episode of This Is Why, Dr. Busti will dig into tricyclic antidepressants (TCA) — not just as legacy antidepressants, but as practical tools for neuropathic pain, migraine prophylaxis, fibromyalgia, IBS-related pain, and insomnia. We’ll connect structure (tertiary vs. secondary amines) to mechanism, side effects, and real-world choices, then tackle the big safety issue: sodium-channel blockade → QRS widening/QT prolongation, seizures, and what to do in an overdose (including why hypertonic sodium works). The goal is to make pharmacology easy and make pharmacology relevant.
Chapters
00:00 Introduction to TCAs: Tricyclic Antidepressants
01:45 TCA Modern Indications: Neuropathic Pain, Fibromyalgia, Insomnia & MDD
02:36 TCA Drug Lineup: Tertiary vs Secondary Amines
04:06 Mechanism of Action: Serotonin vs Norepinephrine Reuptake & Structure Differences
05:31 TCA Clinical Uses & Pain Syndromes: IBS, Neuralgia, Migraine Prophylaxis
12:40 Side Effects: Anticholinergic Burden, Sedation, Orthostasis & CNS Toxicity
16:11 Receptor Targets: Histamine, Alpha-1, Muscarinic & Sodium Channel Effects
18:47 Warnings & contraindications (suicidality, MAOIs, cardiac risk)
20:10 Pharmacokinetics & Metabolism: CYP Pathways, Active Metabolites & Drug Interactions
21:06 Drug Interactions (QT Prolongers, serotonergic meds, stimulants)
#TCAPharmacology #TricyclicAntidepressants #PsychiatryPharmacology #medicaleducation #pharmacologymadeeasy
Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.
About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).
Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

TCA Antidepressants Tables
TCA Antidepressants Tables